Mark Hillman - Hillman Capital Management, Inc.
Holding/activity history for GSK plc (GSK)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 97,432 | 3.73 | Reduce 14.78% | 0.52 | $55.19 | $5,377,272 | SEC |
| 2025 Q4 | 114,336 | 3.53 | Reduce 19.36% | 0.69 | $49.04 | $5,607,037 | SEC |
| 2025 Q3 | 141,779 | 3.56 | Reduce 7.09% | 0.23 | $43.16 | $6,119,182 | SEC |
| 2025 Q2 | 152,599 | 3.20 | Reduce 7.60% | 0.24 | $38.40 | $5,859,802 | SEC |
| 2025 Q1 | 165,143 | 3.15 | Reduce 28.56% | 0.83 | $38.74 | $6,397,640 | SEC |
| 2024 Q4 | 231,151 | 2.90 | Add 17.40% | 0.43 | $33.82 | $7,817,527 | SEC |
| 2024 Q3 | 196,896 | 2.76 | Add 0.91% | 0.02 | $40.88 | $8,049,108 | SEC |
| 2024 Q2 | 195,126 | 2.65 | Reduce 16.43% | 0.53 | $38.50 | $7,512,336 | SEC |
| 2024 Q1 | 233,486 | 3.22 | Add 0.04% | <0.01 | $42.87 | $10,009,545 | SEC |
| 2023 Q4 | 233,386 | 2.99 | Add 0.22% | <0.01 | $37.06 | $8,649,285 | SEC |
| 2023 Q3 | 232,864 | 3.25 | Reduce 0.77% | 0.02 | $36.25 | $8,441,320 | SEC |
| 2023 Q2 | 234,681 | 2.95 | Reduce 1.15% | 0.04 | $35.64 | $8,364,031 | SEC |
| 2023 Q1 | 237,416 | 3.20 | Reduce 0.19% | <0.01 | $35.58 | $8,447,261 | SEC |
| 2022 Q4 | 237,879 | 3.28 | Reduce 2.50% | 0.07 | $35.14 | $8,359,068 | SEC |
| 2022 Q3 | 243,978 | 2.98 | Buy | 2.98 | $29.43 | $7,181,000 | SEC |